Zohydro ER is an oral, single-entity (without acetaminophen) novel extended-release formulation of various strengths of hydrocodone proposed for administration every 12 hours. Zogenix president and chief operating officer
The partnership will leverage the virus-like particle (VLP) vaccine technology of Novavax, malaria vaccine research capabilities of ICGEB and vaccine manufacturing capability of CPLB for the development of
As a part of the agreement, Array will discover novel KIT inhibitor and Clovis is responsible for the pre-clinical and clinical development and commercialisation, as well as development
The Hamburg facility will be equipped with technology from Agilent including multiple RapidFire High-throughput Mass Spectrometry Systems and 6460 Triple Quadrupole instrumentation. Agilent vice president biological systems division
The transaction values HGS at approximately $3.6bn on an equity basis, or approximately $3bn net of cash and debt, and represents a premium of 99% to the HGS
The PLD solution, which is a further enhancement of the Quosa literature management solution, provides a higher level of scalability, automation and usability. Elsevier Quosa general manager Michael
Neupro received the US Food and Drug Administration approval on 3 April 2012. UCB CEO Roch Doliveux said the availability of Neupro is an important step forward for
The products include the new Xpress 100 tablet press, the Xpress 700 and the XL Cota 150 tablet coater. The Xpress product range consists of single and double-sided
Truvada is the first agent to get approval for HIV prevention in uninfected adults, a strategy known as pre-exposure prophylaxis (PrEP). As part of prevention strategy, Gilead has
The shipment represents more than 60 million doses of seasonal influenza vaccine the company plans to deliver to health care providers in the US this influenza season. Sanofi
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.